TECH STARTUPS RESHAPE PERIMENOPAUSE TREATMENT MARKET

The perimenopause sector has evolved from a niche medical concern into a mainstream business opportunity. Tech startups now offer apps, telehealth consultations, and personalized hormone tracking, while established medical groups provide clinical credibility to these offerings. Key players include direct-to-consumer hormone therapy platforms and digital health tools designed specifically for women navigating perimenopause symptoms. This ecosystem combines venture capital investment with medical expertise to address what companies describe as an underserved demographic. Millennial women—now in their 40s and 50s—represent a lucrative market segment with higher digital literacy and disposable income than previous generations experiencing perimenopause. Companies have capitalized on increased awareness of menopause-related health issues and shifting attitudes toward hormone replacement therapy. The movement has expanded access to treatments previously difficult to obtain, though it has also raised questions about medicalization, marketing practices, and whether all women receive necessary clinical evaluation before beginning therapy.